Return to homepagePandemic Pact

Novel Biosensor For Screening And Early Detection Of Covid-19 Patients In High Risk Individuals Living In Long Term Care Homes

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $0

  • Funder

    Peter Wall Institute

  • Principal Investigator

    Babak Shadgan

  • Research Location

    Canada

  • Lead Research Institution

    Department of Orthopaedics, and ICORD, Faculty of Medicine, UBC

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Senior people living in long-term care facilities are among high-risk individuals with the highest rate of mortality when affected by COVID-19. A non-invasive, rapid and sensitive method for regular screening allows early detection of the high-risk individuals infected with COVID-19 helping to reduce the rate of viral transmission in long-term care facilities. Moreover, data indicate better outcomes when treatment protocols start earlier. We aim to develop and test a novel, non-invasive, sensitive and accurate biosensing device and a simple-to-operate method for regular screening and early diagnosis of patients who are affected by COVID-19 in long-term care facilities. Prof. Andrew Macnab, Dr. Jordan Guenette, Dr. Kevin Afra, Dr. Eric Sayre, Dr. Reza Alemi and Dr. Amir Gandjbakhche are key collaborators in this multidisciplinary project.